Table 1.
Baseline Characteristics of Pediatric Patients With MEN2B and PHEO as Compared With the Remaining Patients With MEN2B Who Did Not Develop PHEO
| MEN2B With PHEO | MEN2B Without PHEO | Total MEN2B | |
|---|---|---|---|
| No. of patients | 8 (21%) | 30 (79%) | 38 |
| Sex (F/M) | 5/3 | 12/18 | 17/21 |
| Mean age at MEN2B diagnosisa | 10.5 ± 3.5 (5–17) | 10.1 ± 3.9 (prenatal to 18 y) | 10.6 ± 3.9 (prenatal to 17 y) |
| Mean age at PHEO diagnosisa | 15.2 ± 4.6 (10–25) | N/A | N/A |
| Follow-up, mob | 121.4 ± 82.9 (17–263) | 77.8 ± 45.2 (11–180) | 85.4 ± 55.5 (11–263) |
Abbreviation: N/A, not available.
a
Mean age in years ± SD (range minimum to maximum).
b
Mean period in months ± SD (range minimum to maximum).